This webinar was recorded by BioPharma Asia and published for the first time on their website. https://biopharma-asia.com. It is available here with permission from BioPharma Asia and the presenters. Scroll down to see a copy of the webinar Q&A session.
Considered the “next frontier” in cell therapy and regenerative medicine, exosomes are a type of extracellular vesicle and play a key role in regulating intercellular communication processes.
VivaZome’s David Haylock presents the upstream production of angiogenic exosomes using the fixed-bed iCELLis® nano-bioreactor.
Participants will be able to:
- Compare the performance of the iCELlis Nano bioreactor with traditional flasks for producing adherent cell culture exosomes
- Understand how an end-to-end integrated platform delivers coherently sized, highly purified exosomes
- Discover an innovative scalable cGMP exosome production platform